These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6105793)

  • 41. Improvement in tardive dyskinesia after muscimol therapy.
    Tamminga CA; Crayton JW; Chase TN
    Arch Gen Psychiatry; 1979 May; 36(5):595-8. PubMed ID: 35117
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dyskinesia induced by long-term treatment with antipsychotic drugs: involvement of pre- and postsynaptic dopaminergic mechanisms.
    Engel J; Liljequist S; Goldstein M
    Adv Biochem Psychopharmacol; 1980; 23():387-95. PubMed ID: 6104913
    [No Abstract]   [Full Text] [Related]  

  • 43. Full remission of tardive dyskinesia following general anaesthesia.
    Johnsen M; Wester K
    J Neurol; 2002 May; 249(5):622-5. PubMed ID: 12021954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Are movement disorders the most serious side effects of maintenance therapy with antipsychotic drugs?
    Lidsky TI; Labuszewski T; Levine FM
    Biol Psychiatry; 1981 Dec; 16(12):1189-94. PubMed ID: 6130799
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Tardive dyskinesia: etiology, clinical features and therapy].
    Furer V; Lichtenberg P; Heresco-Levy U
    Harefuah; 2001 Mar; 140(3):248-52. PubMed ID: 11303354
    [No Abstract]   [Full Text] [Related]  

  • 46. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
    Kane JM
    J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What may be gained from neuropsychological investigations of tardive dyskinesia?
    Cohen H; Cohen D
    Brain Cogn; 1993 Sep; 23(1):1-7. PubMed ID: 8105818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Tardive dyskinesia].
    Ruffieux A; Regli F
    Rev Med Suisse Romande; 1985 Apr; 105(4):339-47. PubMed ID: 2861647
    [No Abstract]   [Full Text] [Related]  

  • 49. [Neuroleptics and nicotine].
    Erdmann R
    Psychiatr Prax; 1995 Nov; 22(6):223-7. PubMed ID: 8570751
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The mechanism of tardive dyskinesia occurring following the chronic use of neuroleptics].
    Levin SL
    Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(4):99-104. PubMed ID: 7907203
    [No Abstract]   [Full Text] [Related]  

  • 51. Epidemiology and pathophysiology of tardive dyskinesias.
    Klawans HL; Tanner CM; Goetz CG
    Adv Neurol; 1988; 49():185-97. PubMed ID: 2894124
    [No Abstract]   [Full Text] [Related]  

  • 52. [Tardive dyskinesia].
    Säkö E; Marttila R; Rinne UK
    Duodecim; 1982; 98(13):1008-15. PubMed ID: 6127202
    [No Abstract]   [Full Text] [Related]  

  • 53. Neuronal basis of neuroleptic-induced extrapyramidal side effects.
    Ossowska K
    Pol J Pharmacol; 2002; 54(4):299-312. PubMed ID: 12523484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tardive dyskinesia: preclinical and clinical aspects.
    Gattaz WF; Gerlach J
    Eur Arch Psychiatry Clin Neurosci; 1993; 243(2):116-8. PubMed ID: 8105897
    [No Abstract]   [Full Text] [Related]  

  • 55. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The neuropharmacology of tardive dyskinesia, spontaneous dyskinesia, and other dystonias.
    Stahl SM; Davis KL; Berger PA
    J Clin Psychopharmacol; 1982 Oct; 2(5):321-8. PubMed ID: 6127351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopaminergic and GABAergic aspects of tardive dyskinesia [proceedings].
    Casey DE; Gerlach J; Magelund G; Christensen TR
    Psychopharmacol Bull; 1981 Jan; 17(1):49-50. PubMed ID: 7232658
    [No Abstract]   [Full Text] [Related]  

  • 59. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    Bitton V; Melamed E
    J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pathophysiology and therapy of L-Dopa-induced dyskinesia].
    Hadj Tahar A; Bézard E; Grondin R; Gross CE; Bédard PJ
    Rev Neurol (Paris); 2003 Dec; 159(12):1125-42. PubMed ID: 14978413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.